Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Abbott India Q1 net profit down 35 percent at Rs 48 crore

      Abbott India Q1 net profit down 35 percent at Rs 48 crore

      Ruby Khatun Khatun10 Aug 2017 9:16 AM IST
      New Delhi: Pharmaceuticals firm Abbott India on Tuesday reported 34.8 per cent decline in net profit to Rs 48.25 crore for the first quarter ended...
      Godrej initiates dialogue on importance of partnerships and collaborations for malaria elimination

      Godrej initiates dialogue on importance of partnerships and collaborations for malaria elimination

      Ruby Khatun Khatun10 Aug 2017 9:15 AM IST
      Mumbai: 'Achieving a malaria-free India', a first-of-its-kind conclave, organized by the Godrej Group in partnership with the Vector Control Research...
      Government forms panel to make drugs more affordable

      Government forms panel to make drugs more affordable

      Ruby Khatun Khatun9 Aug 2017 10:00 AM IST
      New Delhi: The government has formed a committee in its bid to make drugs more affordable in the country, Parliament was informed on...
      Cure.fit signs a 100 Crore partnership with Hrithik Roshan lifestyle and fitness brand HRX

      Cure.fit signs a 100 Crore partnership with Hrithik Roshan lifestyle and fitness brand HRX

      Ruby Khatun Khatun9 Aug 2017 10:00 AM IST
      Mumbai: Health and wellness startup Cure.fit has signed Rs 100 Crore partnership with renowned Bollywood star, Hrithik Roshan, who will promote...
      FDA approves Vyxeos to treat certain types of poor-prognosis acute myeloid leukemia

      FDA approves Vyxeos to treat certain types of poor-prognosis acute myeloid leukemia

      Ruby Khatun Khatun9 Aug 2017 9:22 AM IST
      The U.S. Food and Drug Administration (FDA) approved Vyxeos for the treatment of adults with two types of acute myeloid leukemia (AML): newly...
      140 Research Projects on medicinal plants are being currently supported by NMPB: Shripad Naik

      140 Research Projects on medicinal plants are being currently supported by NMPB: Shripad Naik

      Ruby Khatun Khatun9 Aug 2017 9:21 AM IST
      New Delhi: The Minister of State (Independent Charge) for AYUSH, Shri Shripad Naik in written reply to a question in Rajya Sabha has informed that 140...
      Jubilant Life gets USFDA nod for spasticity management drug

      Jubilant Life gets USFDA nod for spasticity management drug

      Ruby Khatun Khatun9 Aug 2017 9:20 AM IST
      New Delhi: Drug firm Jubilant Life Sciences on Saturday said it has received final approval from the US health regulator for its Tizanidine...
      Wockhardt gets USFDA nod for antibiotic injection

      Wockhardt gets USFDA nod for antibiotic injection

      Ruby Khatun Khatun9 Aug 2017 9:18 AM IST
      New Delhi: Drug firm Wockhardt has received approval from the US health regulator for its generic Oxacillin injection used for treatment of bacterial...
      Siemens to update medical scanner software to deal with security bugs

      Siemens to update medical scanner software to deal with security bugs

      Ruby Khatun Khatun9 Aug 2017 9:16 AM IST
      FRANKFURT: German industrial group Siemens expects to update software in some of its medical scanners by the end of the month to deal with...
      Uttar Pradesh to ban manufacture, sale of Pan Masala, Gutka

      Uttar Pradesh to ban manufacture, sale of Pan Masala, Gutka

      Ruby Khatun Khatun9 Aug 2017 9:15 AM IST
      Lucknow: The Uttar Pradesh government is likely to ban the manufacture and sale of the Pan Masala and Gutka in the state.The Yogi Adityanath...
      Dialysis units, pacemakers to cost more under GST, clarifies Health Ministry

      Dialysis units, pacemakers to cost more under GST, clarifies Health Ministry

      Ruby Khatun Khatun8 Aug 2017 11:30 AM IST
      New Delhi: People may have to shell out more for availing of some of the healthcare services such as dialysis, pacemaker implantation, support devices...
      No Clinical trials on humans for proven drugs: New Proposal

      No Clinical trials on humans for proven drugs: New Proposal

      Ruby Khatun Khatun8 Aug 2017 10:00 AM IST
      New Delhi: In order to make new drugs available for critical diseases and to reduce their costs in Indian market, health ministry is planning to waive...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok